Email this article METASTASIS OF RENAL CANCER TO BREAST: DESCRIPTION OF CLINICAL CASE
- Authors: Chernova E.V.1, Khaylenko V.A.1,2, Zhukova L.G.2, Abdullaev A.G.2, Komov D.V.2, Lyubchenko L.N.2, Khaylenkо A.V.1,2, Kudashkin N.E.2,3, Burov D.A.2
-
Affiliations:
- Department of Oncology the Faculty of Additional Professional Education, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
- Department of Oncology and Radiation Therapy the Faculty of Additional Professional Education, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
- Issue: Vol 14, No 3 (2018)
- Pages: 128-132
- Section: CLINICAL CASE
- Published: 30.09.2018
- URL: https://oncourology.abvpress.ru/oncur/article/view/722
- DOI: https://doi.org/10.17650/1726-9776-2018-14-3-128-132
- ID: 722
Cite item
Full Text
Abstract
The main method of treatment of local stages of clear cell renal cancer is surgical. The question of conducting adjuvant irradiation and chemotherapy after radical operations is open. Patients with solitary distant metastases and a favorable prognosis may become candidates for surgical treatment. Surgical removal of isolated solitary metastases allows to achieve 35–60 % of 5-year overall survival. The patient, observed in N.N. Blokhin National Medical Research Center of Oncology with metastasis of renal cancer in the pancreas, and then in the breast is an extremely rare clinical case presented in this article.
Keywords
About the authors
E. V. Chernova
Department of Oncology the Faculty of Additional Professional Education, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Author for correspondence.
Email: bristols@list.ru
ORCID iD: 0000-0002-1613-608X
1 Ostrovityanova St., Moscow 117997.
Russian FederationV. A. Khaylenko
Department of Oncology the Faculty of Additional Professional Education, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia1 Ostrovityanova St., Moscow 117997; 23 Kashirskoe Shosse, Moscow 115478. Russian Federation
L. G. Zhukova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
23 Kashirskoe Shosse, Moscow 115478.
Russian FederationA. G. Abdullaev
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
23 Kashirskoe Shosse, Moscow 115478.
Russian FederationD. V. Komov
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
23 Kashirskoe Shosse, Moscow 115478.
Russian FederationL. N. Lyubchenko
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
23 Kashirskoe Shosse, Moscow 115478.
Russian FederationA. V. Khaylenkо
Department of Oncology the Faculty of Additional Professional Education, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia1 Ostrovityanova St., Moscow 117997; 23 Kashirskoe Shosse, Moscow 115478. Russian Federation
N. E. Kudashkin
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia; Department of Oncology and Radiation Therapy the Faculty of Additional Professional Education, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
23 Kashirskoe Shosse, Moscow 115478; 1 Ostrovityanova St., Moscow 117997.
Russian FederationD. A. Burov
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
23 Kashirskoe Shosse, Moscow 115478.
Russian FederationReferences
- Malignant tumors inRussia in 2015 (morbidity and mortality).Eds.: А.D. Kaprin, V.V. Starinskiy,G.V. Petrova. Moscow: MNIOIim. P.A. Gertsena – filial FGBU “NMIRTS”Minzdrava Rossii, 2017. 250 p. (In Russ.).
- Dimitriadis J., Bamias A. Adjuvant therapyin renal-cell carcinoma: Is it prime timeyet? Translat Cancer Res 2017;6(2):360–2.
- Wahner-Roedler D.L., Sebo T.J. Renal cellcarcinoma: diagnosis based on metastatic manifestations. Mayo Clin Proc1997;72(10):935–41. PMID: 9379697.
- Falco G., Buggi F., Sanna P.A. et al. Breast metastases from a Renal Cell Carcinoma. A case report and review of the literature. Int J Surg Case Rep 2014;5(4):193–5. doi: 10.1016/j.ijscr.2014.01.019. PMID: 24632302.
- Sindoni A., Rizzo M., Tuccari G. et al. Thyroid metastases from renal cellcarcinoma: review of the literature. Scientific World Journal 2010;10:590–602. doi: 10.1100/tsw.2010.55.PMID: 20364245.
- Cheng S.K., Chuah K.L. Metastatic renalcell carcinoma to the pancreas: a review.Arch Pathol Lab Med 2016;140(6):598–602. doi: 10.5858/arpa.2015-0135-RS. PMID: 27232353.
- Tatoğlu M.T., Ozülker T., Değirmenci H.,Sayιlgan A.T. Subcutaneous fatty tissuemetastasis from renal cell carcinoma detected with fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging. Indian J Nucl Med 2011;26(1):27–30. doi: 10.4103/0972-3919.84608. PMID: 21969776.
- Surov A., Hainz M., Holzhausen H.J. et a l. Skeletal muscle metastases: primarytumours, prevalence, and radiological features. Eur Radiol 2010;20(3):649–58.doi: 10.1007/s00330-009-1577-1.PMID: 19707767.
- Rasco D.W., Assikis V., Marshall F. Integrating metastasectomy in the management of advanced urological malignancies – where are we in 2005? J Urol2006;176(5):1921–6. doi: 10.1016/j.juro.2006.07.003. PMID: 17070212.
- Sperti C., Moletta L., Patanè G. Metastatic tumors to the pancreas: the role of surgery. World J Gastrointest Oncol2014;6(10):381–92. doi: 10.4251/wjgo.v6.i10.381. PMID: 25320654.
- Ravaud A., Motzer R.J., Pandha H.S. et a l. Adjuvant sunitinib in high-risk renalcell carcinoma after nephrectomy. N EnglJ Med 2016;375(23):2246–54.doi: 10.1056/NEJMoa1611406.PMID: 27718781.
- Matveev V.B., Roshchin D.A., Peters M.V. Treatment of patients with generalized kidney cancer. Report: Palliative nephrectomy with generalized kidney cancer. Vestnik Moskovskogo onkologicheskogo obshchestva = Bulletin of the Moscow Cancer Society 2010;(3):19. (In Russ.).
- Alekseev B.Ya., Rusakov I.G., Kalpinskiy A.S. Treatment of patients with generalized kidney cancer. Report: Targeted therapy in the treatment of patients with metastatic kidney cancer. Vestnik Moskovskogo onkologicheskogo obshchestva = Bulletin of the Moscow Cancer Society 2010;(3):17. (In Russ.).
- Mazza C., Escudier B., Albiges L. Nivolumab in renal cell carcinoma: latest evidence and clinical potential. Ther Adv Med Oncol 2017;9(3):171–81. doi: 10.1177/1758834016679942. PMID: 28344662.
- Hirota T., Tomida T., Iwasa M. et al. Solitary pancreatic metastasis occurring eight years after nephrectomy for renal cell carcinoma. A case report and surgical review. Int J Pancreatol 1996;19(2):145– 53. doi: 10.1007/BF02805229. PMID: 8723558.
Supplementary files
